FIELD: pharmaceuticals.
SUBSTANCE: invention relates to novel coumarin derivative of the following formula (I) or pharmaceutically acceptable salt or hydrate thereof, where R1 and R2 are the same or different and are (a) phenyl optionally substituted by alkoxy, alkyl, cyano, nitro, hydroxy, trifluoromethyl, amino, carboxy, alkoxycarbonyl, phenyl or one or two halogen atoms, (b) pyridyl, (c) alkyl or (d) thienyl, as well as a pharmaceutical agent containing such a compound as active ingredient. .
EFFECT: coumarin derivative of formula I or pharmaceutically acceptable salt and hydrate thereof exhibits excellent inhibitory effect on cartilage destruction and inhibitory effect on the proliferation of synovial cells in a pharmacological test, in which release of sulfated glycosaminoglycans (sGAG) and the proliferation of synovial cells are used as indicators, whereby said compound is very useful as active ingredient of a pharmaceutical composition, such as a preventive or therapeutic agent for the treatment of arthropathy, such as osteoarthritis or chronic rheumatoid arthritis.
23 cl, 11 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
GLUTARIMIDE DERIVATIVES, USE THEREOF, PHARMACEUTICAL COMPOSITION BASED THEREON, SYNTHESIS METHODS THEREOF | 2015 |
|
RU2610274C2 |
GLUTARIMIDE DERIVATIVE, USE THEREOF, PHARMACEUTICAL COMPOSITION BASED THEREON, SYNTHESIS METHOD THEREOF | 2015 |
|
RU2610275C2 |
GLUTARIMIDE DERIVATIVE, USE THEREOF, PHARMACEUTICAL COMPOSITION BASED THEREON, SYNTHESIS METHODS THEREOF | 2013 |
|
RU2610276C1 |
QUINAZOLINE DERIVATIVES INHIBITING EGFR ACTIVITY | 2009 |
|
RU2505534C2 |
DERIVATIVES OF PROPIONIC ACID AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1997 |
|
RU2174121C2 |
PHOSPHOINDOLES AS HIV INHIBITORS | 2005 |
|
RU2393163C2 |
SUBSTITUTED AMINOALKYL- AND AMIDOALKYLBENZOPYRAN DERIVATIVES | 2006 |
|
RU2392276C2 |
AMINO ACID DERIVATIVE AND METHOD OR PREPARATION THEREOF | 1992 |
|
RU2104265C1 |
SUBSTITUTED PYRROLES ACTIVE AS KINASES INHIBITORS | 2013 |
|
RU2666538C2 |
TRICYCLIC PYRROLE DERIVATIVES, METHOD FOR PRODUCTION THEREOF AND USE THEREOF AS KINASE INHIBITORS | 2012 |
|
RU2591191C2 |
Authors
Dates
2018-03-07—Published
2013-09-20—Filed